Ddavp Tablet
FDA Label NDC 55566-2700

20 label sections · Submitted to the FDA by Ferring Pharmaceuticals Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Ferring Pharmaceuticals Inc. for the product Ddavp (NDC 55566-2700). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, central diabetes insipidus, primary nocturnal enuresis, human pharmacokinetics, contraindications, warnings, general, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.